Rhythm Pharmaceuticals, Inc. — Operating Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/acfb4575-8a37-4285-af9f-c09ca203a872/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-192.0M | 2025-01-01 – 2025-12-31 | evidence 0001628280-26-012399 |
| FY 2024 | $-265.5M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-001889 |
| FY 2023 | $-184.4M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002181 |
| FY 2022 | $-179.2M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-002613 |
| FY 2021 | $-170.1M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-002543 |
| FY 2020 | $-136.6M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-002121 |
| FY 2019 | $-146.0M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-001896 |
| FY 2018 | $-78.4M | 2018-01-01 – 2018-12-31 | evidence 0001558370-19-001698 |
| FY 2017 | $-32.4M | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-001923 |
| FY 2016 | $-25.9M | 2016-01-01 – 2016-12-31 | evidence 0001558370-18-001923 |
| FY 2015 | $-10.6M | 2015-01-01 – 2015-12-31 | evidence 0001558370-18-001923 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Rhythm Pharmaceuticals, Inc. — all facts · Revenue · Net Income